摘要
禁止人工智能代开处方规定(以下简称规定)在实践中面临诸多挑战,如注册医师数量难以满足互联网医疗需求、监督执法主体尚待明确、法律责任划分不清、监管强化和成本管控之间的博弈等。规定的出台具有学理和法律依据,对利益相关者,即卫生行政部门、互联网医疗机构和患者都产生了或将产生一定程度的影响,但总体来看利大于弊。因此在利益相关者理论视角下,对各利益相关方提出应对建议,以破解规定施行中的难题,实现互联网诊疗与实体机构诊疗服务最大限度的“同质”。
The provisions prohibiting artificial intelligence from prescribing on behalf of prescriptions(hereinafter referred to as the"Provisions")face many challenges in practice,such as the difficulty of the number of registered physicians to meet the needs of Internet medical treatment,the need to clarify the subject of supervision and law enforcement,the unclear division of legal responsibilities,and the game between regulatory strengthening and cost control.The promulgation of the regulations has a scientific and legal basis,and has or will have a certain degree of impact on stakeholders,i.e.health administrative agencies,Internet medical institutions and patients,but on the whole,the benefits outweigh the disadvantages.Therefore,from the perspective of stakeholder theory,suggestions are put forward for various stakeholders to solve the problems in the implementation of the regulations and achieve the maximum"homogeneity"between Internet diagnosis and treatment and physical institutions'diagnosis and treatment services.
作者
章梦琪
邓勇
Zhang Mengqi;Deng Yong(Department of Law,Beijing University of Traditional Chinese Medicine,Beijing 102488,China)
出处
《卫生法学》
2024年第5期47-51,67,共6页
Health Law
关键词
人工智能
代开处方
利益相关者
应对策略
Artificial intelligence
Prescribing on behalf of others
Stakeholders
Response strategies